-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VktuUjWkDz/NbBzNg23xtDB6l4t/NnhVboQ8DDdHwQXE1tfJwIPuW6/NQKy47STo
 weHk4X8btfiWab3FyHp9gQ==

<SEC-DOCUMENT>0000897069-09-001423.txt : 20090930
<SEC-HEADER>0000897069-09-001423.hdr.sgml : 20090930
<ACCEPTANCE-DATETIME>20090930130554
ACCESSION NUMBER:		0000897069-09-001423
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090928
FILED AS OF DATE:		20090930
DATE AS OF CHANGE:		20090930

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			TAYLOR RICHMOND L
		CENTRAL INDEX KEY:			0001217565

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10670
		FILM NUMBER:		091094973

	MAIL ADDRESS:	
		STREET 1:		4155 E LAPALMA AVE SUITE 400
		CITY:			ANEHEIM
		STATE:			CA
		ZIP:			92807

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HANGER ORTHOPEDIC GROUP INC
		CENTRAL INDEX KEY:			0000722723
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
		IRS NUMBER:				840904275
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		TWO BETHESDA METRO CENTER
		STREET 2:		SUITE 1300
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
		BUSINESS PHONE:		3019860701

	MAIL ADDRESS:	
		STREET 1:		TWO BETHESDA METRO CENTER
		STREET 2:		SUITE 1300
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SEQUEL CORP
		DATE OF NAME CHANGE:	19890814

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELLTECH COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19860304
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4_richmondtaylorex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2009-09-28</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000722723</issuerCik>
        <issuerName>HANGER ORTHOPEDIC GROUP INC</issuerName>
        <issuerTradingSymbol>HGR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001217565</rptOwnerCik>
            <rptOwnerName>TAYLOR RICHMOND L</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>TWO BETHESDA METRO CENTER</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE 1200</rptOwnerStreet2>
            <rptOwnerCity>BETHESDA</rptOwnerCity>
            <rptOwnerState>MD</rptOwnerState>
            <rptOwnerZipCode>20814</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Executive Vice President</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2009-09-28</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>15000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>14.1317</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>53457</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Option to Buy</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>14.23</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2003-05-30</value>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2012-05-29</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>46666</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>46666</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Option to Buy</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>13.80</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2004-08-01</value>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2013-07-31</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>25000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>25000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These shares were sold at a range of sale prices from $14.13 to $14.14. The reporting person will provide upon request by the
 Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at
 each separate price.</footnote>
        <footnote id="F2">Includes (i) unvested restricted shares that total 7,260 shares of stock from an initial grant of 7,260 shares of restricted
 stock made on November 13, 2008; (ii) unvested restricted shares that total 22,500 shares of stock from an initial grant of
 45,000 shares of restricted stock and performance shares made on August 9, 2007; (iii) unvested restricted shares and fully
 vested shares that total 19,917 shares of stock from an initial grant of 40,000 shares of restricted stock made on June 12,
 2006; and (iv) 3,780 shares of stock that were derived from previous grants of restricted shares that are now fully vested.
 All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the
 anniversary date of the grant.</footnote>
        <footnote id="F3">This option was fully vested on June 23, 2005.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Teri L. Champ, attorney-in-fact</signatureName>
        <signatureDate>2009-09-30</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----